What amount sold does Euphrates Vascular, Inc. report in Form D filings?

The latest linked filings report $9.7M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Euphrates Vascular, Inc.'s most recent SEC filing?

Euphrates Vascular, Inc.'s most recent Form D filing was on 2023-10-03.

How many investors does Euphrates Vascular, Inc. have?

The most recent Form D filing lists 33 investor(s).

What type of securities does Euphrates Vascular, Inc. offer?

Euphrates Vascular, Inc.'s SEC Form D filings indicate equity offerings.

Euphrates Vascular, Inc.

CIK: 0001752992·Biotechnology·St. Louis, MO·Corporation·Founded 2018

Reported Sold

$9,674,802

Total Filings

Identified Offerings

Last Filed

Oct 3, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 3, 2023Form D/A — Amendment

Reported sold: $9,084,802 · Target: $9,084,802

Rule 506(b)·33 investors

Changed: Reported amount sold, Offering target, Reported investors

Jun 1, 2021Form D — New notice

Reported sold: $5,984,167 · Target: $7,206,980

Rule 506(b)·25 investors

Sep 17, 2018Form D — New notice

Reported sold: $590,000 · Target: $4,000,000

Rule 506(b)·4 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$120,069

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$9,674,802

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Sean Morris

Related Person

Appears on 2 filings

Thomas Hillman

Related Person

Appears on 1 filing

Eric Moessinger

Related Person

Appears on 1 filing

Robert Mitchell

Related Person

Appears on 1 filing

Jeffrey Blair

Related Person

Appears on 1 filing

Tim Blair

Related Person

Appears on 1 filing

Troy Long

Related Person

Appears on 1 filing

Martin Omid Akhavan

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 3, 2023	Amendment	$9,084,802	$9,084,802	33
Jun 1, 2021	New	$7,206,980	$5,984,167	25
Sep 17, 2018	New	$4,000,000	$590,000	4

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

EVIA Life Sciences Inc.

Biotechnology

Offering target: $5,498,154

Filed Nov 2, 2026